Improving Standard of Care Through VarietyVideo Categories: ASH 2014
How International Standards for Molecular Biomarker Testing in Lung Cancer Have Influenced Which Tests are Routinely Performed
Drs. Roy Herbst and David Rimm discuss the 50-gene panel that has become an ISLC-mandated standard for all patients with lung cancer; however, the components of cancer biomarker testing panels must be fluid and respond to new developments in the field as reported in the literature and/or at international cancer [ Read More ]
Do Therapeutic Agents Affect Healthy Stem Cells?
Dr Wainberg and Dr Gerson ponder and provide opinions on whether these investigational therapies also target healthy cells.